NCCN CNS Tumor Guidelines Update for 2024.
作者信息
Nabors Louis Burt, Hattangadi-Gluth Jona, Horbinski Craig, Portnow Jana
机构信息
Departments of Neurology and Neurosurgery, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Division of Neuro-Oncology, Department of Neurology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
出版信息
Neuro Oncol. 2025 Mar 7;27(3):595-596. doi: 10.1093/neuonc/noae267.
Abstract
摘要
相似文献
1
NCCN CNS Tumor Guidelines Update for 2024.2024年NCCN中枢神经系统肿瘤指南更新
Neuro Oncol. 2025 Mar 7;27(3):595-596. doi: 10.1093/neuonc/noae267.
2
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.NCCN 指南®洞察：中枢神经系统肿瘤，第 2.2022 版。
J Natl Compr Canc Netw. 2023 Jan;21(1):12-20. doi: 10.6004/jnccn.2023.0002.
3
An estimate of rate of deviation from NCCN guideline recommendations for central nervous system imaging in trials forming basis for drug approval in first line advanced non-small cell lung cancer (NSCLC).评估临床试验中中枢神经系统成像偏离 NCCN 指南建议的比率，这些临床试验构成了一线晚期非小细胞肺癌 (NSCLC) 药物批准的基础。
BMC Cancer. 2022 Jan 16;22(1):70. doi: 10.1186/s12885-022-09179-y.
4
NCCN CNS tumor guidelines update for 2023.2023年美国国立综合癌症网络（NCCN）中枢神经系统肿瘤指南更新
Neuro Oncol. 2023 Dec 8;25(12):2114-2116. doi: 10.1093/neuonc/noad169.
5
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.美国国立综合癌症网络（NCCN）工作组报告：胃肠道间质瘤（GIST）患者的管理——NCCN临床实践指南更新
J Natl Compr Canc Netw. 2007 Jul;5 Suppl 2:S1-29; quiz S30.
6
Update on the Implementation of NCCN Guidelines for Distress Management by NCCN Member Institutions.NCCN 成员机构实施 NCCN 精神痛苦管理指南的最新情况。
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1251-1256. doi: 10.6004/jnccn.2019.7358.
7
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.转移性结直肠癌临床实践指南（2013 年第 3 版）：NCCN 指南的重点更新内容。
J Natl Compr Canc Netw. 2013 Feb 1;11(2):141-52; quiz 152. doi: 10.6004/jnccn.2013.0022.
8
International adaptations of NCCN Clinical Practice Guidelines in Oncology.NCCN 肿瘤临床实践指南的国际适应性。
J Natl Compr Canc Netw. 2014 May;12(5):643-8. doi: 10.6004/jnccn.2014.0068.
9
Central Nervous System Cancers, Version 1.2015.中枢神经系统癌症，第 1.2015 版。
J Natl Compr Canc Netw. 2015 Oct;13(10):1191-202. doi: 10.6004/jnccn.2015.0148.
10
2024 SOGC, 2024 NCCN, 2022 ESO-ESMO, and 2018 ASCO: a comparison of female cancer survivorship guidelines for the management of sexual health concerns.2024年加拿大妇产科医师协会（SOGC）、2024年美国国立综合癌症网络（NCCN）、2022年欧洲肿瘤内科学会（ESO）-欧洲医学肿瘤学会（ESMO）以及2018年美国临床肿瘤学会（ASCO）：关于女性癌症幸存者性健康问题管理指南的比较
Support Care Cancer. 2025 Jun 15;33(7):584. doi: 10.1007/s00520-025-09640-1.
引用本文的文献
1
Demonstrating the clinical utility of genomic profiling using cerebrospinal fluid to inform management of central nervous system tumors - a meta analysis of the literature.利用脑脊液进行基因组分析以指导中枢神经系统肿瘤管理的临床效用——文献的荟萃分析
J Liq Biopsy. 2025 Jul 25;9:100317. doi: 10.1016/j.jlb.2025.100317. eCollection 2025 Sep.
2
Analytical Validation and Clinical Sensitivity of the Belay Summit Assay for the Detection of DNA Variants in Cerebrospinal Fluid of Primary and Metastatic Central Nervous System Cancer.用于检测原发性和转移性中枢神经系统癌症脑脊液中DNA变异的Belay Summit检测法的分析验证和临床敏感性
J Mol Diagn. 2025 Jul;27(7):615-629. doi: 10.1016/j.jmoldx.2025.03.010. Epub 2025 Apr 23.
本文引用的文献
1
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.沃拉西尼布和伊沃西尼布治疗 IDH1 突变型低级别胶质瘤：一项随机、围手术期的 1 期临床试验。
Nat Med. 2023 Mar;29(3):615-622. doi: 10.1038/s41591-022-02141-2. Epub 2023 Feb 23.
2
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis.随机Ⅱ期临床试验：质子颅脊髓放疗对比光子累及野放疗治疗实体瘤性脑膜转移瘤患者。
J Clin Oncol. 2022 Nov 20;40(33):3858-3867. doi: 10.1200/JCO.22.01148. Epub 2022 Jul 8.
Zotero 插件